BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Nicola AF, Meyer M, Guennoun R, Schumacher M, Hunt H, Belanoff J, de Kloet ER, Gonzalez Deniselle MC. Insights into the Therapeutic Potential of Glucocorticoid Receptor Modulators for Neurodegenerative Diseases. Int J Mol Sci 2020;21:E2137. [PMID: 32244957 DOI: 10.3390/ijms21062137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 de Azevedo Camin N, Andrey Ariza Traslaviña G, Cleber Gama de Barcellos Filho P, Rodrigues Franci C. Early post-stress administration of MR or GR antagonist in adolescent female rats restored anxiogenic-like behavior and modified the HPA axis response in the adulthood. Brain Research 2022. [DOI: 10.1016/j.brainres.2022.147833] [Reference Citation Analysis]
2 Mentis AA, Bougea AM, Chrousos GP. Amyotrophic lateral sclerosis (ALS) and the endocrine system: Are there any further ties to be explored? Aging Brain 2021;1:100024. [DOI: 10.1016/j.nbas.2021.100024] [Reference Citation Analysis]
3 Chen L, Shi R, She X, Gu C, Chong L, Zhang L, Li R. Mineralocorticoid receptor antagonist‐mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF‐H 2 S‐Nrf2 signaling. Fundam Clin Pharmacol 2020;34:697-707. [DOI: 10.1111/fcp.12576] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]